Publications

Detailed Information

Perfusion Computed Tomography Evaluation of Cerebral Hemodynamic Impairment in Patients With Unilateral Chronic Steno-Occlusive Disease: A Comparison With the Acetazolamide Challenge (99m)Tc-Hexamethylpropyleneamine Oxime Single-Photon Emission Computed Tomography

DC Field Value Language
dc.contributor.authorKim, Eunhee-
dc.contributor.authorSohn, Chul-Ho-
dc.contributor.authorNa, Dong Gyu-
dc.contributor.authorKim, Jeong Eun-
dc.contributor.authorKim, Ji-hoon-
dc.contributor.authorJeon, Se Jeong-
dc.contributor.authorChang, Kee-Hyun-
dc.date.accessioned2012-06-26T06:26:40Z-
dc.date.available2012-06-26T06:26:40Z-
dc.date.issued2009-08-
dc.identifier.citationJOURNAL OF COMPUTER ASSISTED TOMOGRAPHY; Vol.33 4; 546-551ko_KR
dc.identifier.issn0363-8715-
dc.identifier.urihttps://hdl.handle.net/10371/77457-
dc.description.abstractPurpose: The purpose of this study was to determine which pefusion computed tomography (PCT) parameter is the most valid predictor of cerebral vascular reserve (CVR) as determined by (99m)Tc-hexamethylpropylencamine oxime single-photon emission computed tomography (SPECT). Methods: Single-photon emission computed tomography with acetazolamide challenge and PCT were used in 23 patients with unilateral steno-occlusive vascular disease. After coregistration of the PCT and SPECT images, we assessed the relationship between the PCT parameters and SPECT findings and the predictive values of the PCT parameters for decreased CVR. Results: All PCT parameters of cerebral blood flow, cerebral blood volume, and mean transit time (MTT) were significantly correlated with SPECT regional cerebral blood flow ratios (P < 0.01). The MTT values more strongly correlated with acetazolamide effect than with cerebral blood volume or cerebral blood flow (P < 0.001). The MTT difference (values in the pathological hemisphere minus the values in the contralateral hemisphere) was a threshold of 1.5 seconds, with a sensitivity of 88% and a specificity of 70% for predicting decreased CVR. Conclusion: Mean transit time is the most predictive parameter for assessing decreased CVR in patients with unilateral steno-occlusive vascular disease.ko_KR
dc.language.isoenko_KR
dc.publisherLIPPINCOTT WILLIAMS & WILKINSko_KR
dc.subjectSPECTko_KR
dc.subjectPCTko_KR
dc.subjectcerebral vascular reserveko_KR
dc.titlePerfusion Computed Tomography Evaluation of Cerebral Hemodynamic Impairment in Patients With Unilateral Chronic Steno-Occlusive Disease: A Comparison With the Acetazolamide Challenge (99m)Tc-Hexamethylpropyleneamine Oxime Single-Photon Emission Computed Tomographyko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김은희-
dc.contributor.AlternativeAuthor손철호-
dc.contributor.AlternativeAuthor나동규-
dc.contributor.AlternativeAuthor김정은-
dc.contributor.AlternativeAuthor장기현-
dc.contributor.AlternativeAuthor김지훈-
dc.contributor.AlternativeAuthor전세정-
dc.identifier.doi10.1097/RCT.0b013e318188887d-
dc.citation.journaltitleJOURNAL OF COMPUTER ASSISTED TOMOGRAPHY-
dc.description.citedreferenceChen A, 2006, AM J NEURORADIOL, V27, P1876-
dc.description.citedreferenceWintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39-
dc.description.citedreferenceYata K, 2006, STROKE, V37, P534, DOI 10.1161/01.STR.0000199085.40000.cf-
dc.description.citedreferenceWintermark M, 2006, AM J NEURORADIOL, V27, P26-
dc.description.citedreferenceMiyazawa N, 2005, CLIN NEUROL NEUROSUR, V108, P11, DOI 10.1016/j.clineuro.2004.12.024-
dc.description.citedreferenceEskey CJ, 2005, NEUROIMAG CLIN N AM, V15, P367, DOI 10.1016/j.nic.2005.05.002-
dc.description.citedreferenceIto H, 2005, ANN NUCL MED, V19, P65-
dc.description.citedreferenceESKEY CJ, 2005, NEUROIMAG CLIN N AM, V15, pR11-
dc.description.citedreferenceKealey SM, 2004, RADIOLOGY, V231, P587, DOI 10.1148/radiol.2312030489-
dc.description.citedreferenceLee HY, 2004, J NUCL MED, V45, P202-
dc.description.citedreferenceKudo K, 2003, AM J NEURORADIOL, V24, P419-
dc.description.citedreferenceWintermark M, 2002, STROKE, V33, P2025-
dc.description.citedreferenceDerdeyn CP, 2002, BRAIN, V125, P595-
dc.description.citedreferenceEastwood JD, 2002, AM J NEURORADIOL, V23, P285-
dc.description.citedreferenceEastwood JD, 2002, RADIOLOGY, V222, P227-
dc.description.citedreferenceKuroda S, 2001, STROKE, V32, P2110-
dc.description.citedreferenceRoberts HC, 2001, AM J NEURORADIOL, V22, P1077-
dc.description.citedreferenceWintermark M, 2001, EUR RADIOL, V11, P1220-
dc.description.citedreferenceSchumann P, 1998, BRAIN, V121, P1369-
dc.description.citedreferenceASENBAUM S, 1995, NEURORADIOLOGY, V37, P13-
dc.description.citedreferenceKNOP J, 1992, STROKE, V23, P1733-
dc.description.citedreferenceYAMASHITA T, 1991, NEURORADIOLOGY, V33, P217-
dc.description.citedreferenceGEMMELL HG, 1990, J NUCL MED, V31, P1595-
dc.description.citedreferenceHEISS WD, 1990, J CEREBR BLOOD F MET, V10, P687-
dc.description.citedreferenceSETTE G, 1989, BRAIN, V112, P931-
dc.description.citedreferencePOWERS WJ, 1987, ANN INTERN MED, V106, P27-
dc.description.citedreferenceGIBBS JM, 1984, LANCET, V1, P182-
dc.description.citedreferenceAXEL L, 1983, INVEST RADIOL, V18, P94-
dc.description.tc2-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share